Clinical Trial Update: DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the role of topical nepacetan (Nepafenac) for cystoid macular edema in patients undergoing DSAEK or DMEK.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystoid Macular Edema
• Descemet Membrane Endothelial Keratoplasty
• Descemet Stripping Automated Endothelial Keratoplasty

Drugs mentioned

• Nepafenac (nepafenac)

Snippet

Sponsor: Oslo University Hospital | Conditions: Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Descemet Membrane Endothelial Keratoplasty (DMEK) | Phase 4 | Status: RECRUITING